These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22075185)

  • 1. Challenges of supplementary treatment for neurodegenerative diseases.
    Matsuo M
    Brain Dev; 2012 Feb; 34(2):85-6. PubMed ID: 22075185
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel treatments and future perspectives: outcomes of intrathecal drug delivery.
    Dickson PI
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S124-7. PubMed ID: 20040323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoamide dehydrogenase deficiency due to a novel mutation in the interface domain.
    Shany E; Saada A; Landau D; Shaag A; Hershkovitz E; Elpeleg ON
    Biochem Biophys Res Commun; 1999 Aug; 262(1):163-6. PubMed ID: 10448086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacology of neurodegenerative diseases: perspectives on cellular and gene therapies].
    Finiels F
    Therapie; 1998; 53(1):31-4. PubMed ID: 9773097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging therapies for neurodegenerative lysosomal storage disorders - from concept to reality.
    Hemsley KM; Hopwood JJ
    J Inherit Metab Dis; 2011 Oct; 34(5):1003-12. PubMed ID: 21584766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology insight: therapeutic RNA interference--how far from the neurology clinic?
    Gonzalez-Alegre P; Paulson HL
    Nat Clin Pract Neurol; 2007 Jul; 3(7):394-404. PubMed ID: 17611488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer therapy for neurodegenerative disorders.
    Feigin A; Eidelberg D
    Mov Disord; 2007 Jul; 22(9):1223-8; quiz 1369. PubMed ID: 17393533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degenerative and inherited neurological disorders.
    Lowenstein PR
    Mol Cell Biol Hum Dis Ser; 1995; 5():307-49. PubMed ID: 9532573
    [No Abstract]   [Full Text] [Related]  

  • 9. A wake-up call: are degenerative diseases provoked by some of our normal food constituents? A case for nutrigenomics.
    Andersen MT; Søndergaard I
    Med Hypotheses; 2007; 68(1):229-30. PubMed ID: 16965861
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitochondrial dysfunction in mouse trisomy 16 brain.
    Bambrick LL; Fiskum G
    Brain Res; 2008 Jan; 1188():9-16. PubMed ID: 18061151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can endogenous stem cells be stimulated to repair the degenerating brain?
    Michell AW; Phillips W; Barker RA
    J Pharm Pharmacol; 2004 Oct; 56(10):1201-10. PubMed ID: 15482633
    [No Abstract]   [Full Text] [Related]  

  • 12. Nutraceuticals in Neurodegeneration and Aging.
    Ong WY; Sun GY; Wood WG; Lin TN
    Neuromolecular Med; 2016 Sep; 18(3):239-40. PubMed ID: 27507593
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating inflammation in childhood neurodegenerative disorders.
    Lim M
    Dev Med Child Neurol; 2011 Apr; 53(4):298-304. PubMed ID: 21309766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonviral siRNA delivery for gene silencing in neurodegenerative diseases.
    Prakash S; Malhotra M; Rengaswamy V
    Methods Mol Biol; 2010; 623():211-29. PubMed ID: 20217554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic defect of pyruvate dehydrogenase].
    Koike K; Urata Y
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):663-5. PubMed ID: 3270880
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gene and gene cellular therapy and neurodegenerative diseases].
    Ugriumov MV; Ermakov AS; Popov AP; Zhdanov RI
    Vopr Med Khim; 2000; 46(3):311-23. PubMed ID: 11033889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi therapy for neurodegenerative diseases.
    Boudreau RL; Davidson BL
    Curr Top Dev Biol; 2006; 75():73-92. PubMed ID: 16984810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can flies help humans treat neurodegenerative diseases?
    Marsh JL; Thompson LM
    Bioessays; 2004 May; 26(5):485-96. PubMed ID: 15112229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic gene silencing strategies for polyglutamine disorders.
    Scholefield J; Wood MJ
    Trends Genet; 2010 Jan; 26(1):29-38. PubMed ID: 19962779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perspectives on postgenome medicine: Neurodegenerative disease].
    Osaka H; Wada K
    Nihon Rinsho; 2001 Jan; 59(1):119-25. PubMed ID: 11197841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.